Stephen Kennedy Smith
Founder at Pear Therapeutics (US), Inc.
Profile
Stephen Kennedy Smith is the founder of Pear Therapeutics (US), Inc., where he holds the title of Executive Vice President-Corporate Development.
Pear Therapeutics (US), Inc. was founded in 2013.
He also served as a Director at Med-Design Corp.
In terms of education, Mr. Smith holds graduate degrees from The Trustees of Columbia University in The City of New York, Harvard University, and Harvard Graduate School of Education.
Stephen Kennedy Smith active positions
| Companies | Position | Start |
|---|---|---|
Pear Therapeutics (US), Inc.
 Pear Therapeutics (US), Inc. Packaged SoftwareTechnology Services Pear Therapeutics (US), Inc. develops and provides a platform that combines pharmaceutical preparations with scientifically validated software applications. It offers eFormulation, pharmaceutical-software combination products. The firm combines digital therapies with supplements, medical foods and pharmaceuticals to create more effective treatment solutions. The company was founded in 2013 by Corey M. McCann, Stephen Kennedy Smith and William Greene and is headquartered in Boston. MA. | Founder | 12/06/2014 |
Former positions of Stephen Kennedy Smith
| Companies | Position | End |
|---|---|---|
| Med-Design Corp. | Director/Board Member | 07/06/2006 |
Training of Stephen Kennedy Smith
| Harvard University | Graduate Degree |
| The Trustees of Columbia University in The City of New York | Graduate Degree |
| Harvard Graduate School of Education | Graduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
| Med-Design Corp. | Health Technology |
Pear Therapeutics (US), Inc.
Pear Therapeutics (US), Inc. Packaged SoftwareTechnology Services Pear Therapeutics (US), Inc. develops and provides a platform that combines pharmaceutical preparations with scientifically validated software applications. It offers eFormulation, pharmaceutical-software combination products. The firm combines digital therapies with supplements, medical foods and pharmaceuticals to create more effective treatment solutions. The company was founded in 2013 by Corey M. McCann, Stephen Kennedy Smith and William Greene and is headquartered in Boston. MA. | Technology Services |
- Stock Market
- Insiders
- Stephen Kennedy Smith
